They lost about 4.8% more weight on average than those who took a fake pill (placebo)
Neither status makes a telehealth company automatically unsafe, but the absence of third-party verification means patients must evaluate the platform's clinical protocols more carefully on their own
A 2025 systematic review published in Cureus analyzed five studies encompassing 2,905 adult patients using GLP-1 receptor agonists
Acknowledgements This study was supported by National Key Research and Development Plan Precision Medicine Research (2017YFSF090203), the National Natural Science Foundation of China (81470840, 81873565 and 81800510), Shanghai Sailing Program (18YF1415900), VA Merit Award (I01BX004033 and I01BX001390), and Research Career Scientist Award (IK6BX004477)
Let the vial warm to room temperature while sealed to reduce condensation
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial